Long-term complications from subcutaneous ICDs assessed

The real-world complication rate of subcutaneous implantable cardioverter defibrillators (ICDs) is about 9% during two years, a study shows.
But pocket haematomas are “very strong predictors” of more severe infective complications, the researchers say.
In the European registry study, 1254 patients (median age 52, 78% male, 31% ischaemic) implanted with ICDs from 2015-2020 were followed for complications.
Over a median follow-up of 23 months, 127 device-related complications were observed in 117 patients (9.3%).